References

 

References for "Guidance on the intravenous use of colistimethate sodium (colistin) in adults"

  1. Tsuji BT, Pogue JM, Zavascki AP, et al. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy 2019;39(1):10-39
  2. Chien HT, Lin YC, Sheu CC, et al. Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis. Int J Antimicrob Agents 2020;55(3):105889. doi: 10.1016/j.ijantimicag.2020.105889
  3. Levy HG, Gould I et al. Detection, Treatment and Prevention of Carbapenemase-Producing Enterobacteriaceae: Recommendations for an International Working Group. Journal of Chemotherapy 2013, 25 (3): 129-140
  4. Summary of Product Characteristics (Colisitimethate Sodium 1 Million I.U. Powder for Solution for Injection, Beacon Pharmaceuticals / Kent Pharma UK Ltd. Last updated 01 May 2019. Accessed 09/09/22
  5. Summary of Product Characteristics (Colomycin 1 million International Units (IU) Powder for solution for injection, infusion or inhalation. Teva UK Ltd. Last updated 12 July 2023. Accessed 02/09/26
  6. Gauthier TP, Wolowich WR, Reddy A, et al. Incidence and predictors of nephrotoxicity associated with intravenous colistin in overweight and obese patients. Antimicrob Agents Chemother. 2012 May;56(5):2392-6. doi: 10.1128/AAC.00028-12. Epub 2012 Feb 27. Erratum in: Antimicrob Agents Chemother. 2012 Jun;56(6):3473.  
  7. Pogue JM, Lee J et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis 2011; 53:879-84
  8. Gilbert DN. Polymyxin E, Colistin monograph. Last updated Nov 10 2020. Sanford Guide Web Edition. Accessed 04/11/22
  9. Nation RL, Garonzik SM, Thamlikitkul V, et al. Dosing guidance for intravenous colistin in critically-ill patients. Clin Infect Dis. 2017;64(5):565-571.
  10. Colistimethate sodium monograph Version 4 – T1. Published 12/04/2026. Medusa NHS Injectable Medicines Guide. Accessed 02/09/26.
  11. Grayson ML, Cosgrove SE, Crowe S, et al. Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs. 7th ed. CRC Press; 2017.
  12. Colistimethate Sodium. In IBM Micromedex® DRUGDEX® (electronic version). IBM Watson Health, Greenwood Village, Colorado, USA. Accessed 06/11/22.
  13. Antibiotic Guideline Ranges 2026-2027 Version 1.13. 1st July 2026. Antimicrobial Reference Laboratory. Severn Pathology, NHS North Bristol

Content updated October 2026